Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dilani Angela Solaman"'
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:80-81
Introduction:Health technology assessments (HTA) for combination drug therapies in oncology are increasingly common. Companies face multiple challenges when determining their economic value due to their complexity and high cost, while payers must bal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::516419a4fd14efd517c15a6084726412
https://doi.org/10.1017/s0266462318002040
https://doi.org/10.1017/s0266462318002040
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:95-95
Introduction:Health technology assessment (HTA) must adapt to support the changing health system landscapes and improve access to valuable innovation under budgetary constraints. This is exemplified by the pricing and reimbursement of high-cost combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcca0e599aaca2a8ccbba7afc2536f83
https://doi.org/10.1017/s0266462318002283
https://doi.org/10.1017/s0266462318002283